BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 17608847)

  • 1. Survival predictors in patients with node-negative gastric carcinoma.
    Lee CC; Wu CW; Lo SS; Chen JH; Li AF; Hsieh MC; Shen KH; Lui WY
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1014-8. PubMed ID: 17608847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant prognostic factors in patients with early gastric cancer.
    Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Takahashi M; Kikuchi S; Yamauchi H
    Int Surg; 2000; 85(4):286-90. PubMed ID: 11589593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors of node-negative gastric carcinoma: univariate and multivariate analyses.
    Adachi Y; Mori M; Maehara Y; Kitano S; Sugimachi K
    J Am Coll Surg; 1997 Apr; 184(4):373-7. PubMed ID: 9100682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type.
    Adachi Y; Yasuda K; Inomata M; Sato K; Shiraishi N; Kitano S
    Cancer; 2000 Oct; 89(7):1418-24. PubMed ID: 11013353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant prognostic factors in patients with node-negative gastric cancer.
    Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Takahashi M; Kikuchi S; Yamauchi H
    Int Surg; 1999; 84(4):331-6. PubMed ID: 10667813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
    Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
    Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is tumor size a prognostic indicator for gastric carcinoma?
    Yokota T; Ishiyama S; Saito T; Teshima S; Yamada Y; Iwamoto K; Takahashi M; Murata K; Yamauchi H
    Anticancer Res; 2002; 22(6B):3673-7. PubMed ID: 12552975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of lymphatic invasion in patients with node-negative gastric cancer.
    Ichikawa D; Kubota T; Kikuchi S; Fujiwara H; Konishi H; Tsujiura M; Ikoma H; Nakanishi M; Okamoto K; Sakakura C; Ochiai T; Kokuba Y; Otsuji E
    J Surg Oncol; 2009 Aug; 100(2):111-4. PubMed ID: 19475584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologic predictors of survival in node-negative gastric cancer.
    Kooby DA; Suriawinata A; Klimstra DS; Brennan MF; Karpeh MS
    Ann Surg; 2003 Jun; 237(6):828-35; discussion 835-7. PubMed ID: 12796579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of lymphovascular invasion in patients with stage I gastric cancer.
    Kunisaki C; Makino H; Kimura J; Takagawa R; Kosaka T; Ono HA; Akiyama H; Fukushima T; Nagahori Y; Takahashi M
    Surgery; 2010 Feb; 147(2):204-11. PubMed ID: 19878963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for lymph node metastasis in histologically poorly differentiated type early gastric cancer.
    Kunisaki C; Takahashi M; Nagahori Y; Fukushima T; Makino H; Takagawa R; Kosaka T; Ono HA; Akiyama H; Moriwaki Y; Nakano A
    Endoscopy; 2009 Jun; 41(6):498-503. PubMed ID: 19533552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors related to lymph node metastasis and the feasibility of endoscopic mucosal resection for treating poorly differentiated adenocarcinoma of the stomach.
    Park YD; Chung YJ; Chung HY; Yu W; Bae HI; Jeon SW; Cho CM; Tak WY; Kweon YO
    Endoscopy; 2008 Jan; 40(1):7-10. PubMed ID: 18210339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric cancer: establishing predictors of biologic behavior with use of population-based data.
    Dicken BJ; Saunders LD; Jhangri GS; de Gara C; Cass C; Andrews S; Hamilton SM
    Ann Surg Oncol; 2004 Jun; 11(6):629-35. PubMed ID: 15150070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of perineural invasion in patients with gastric cancer who underwent curative resection.
    Bilici A; Seker M; Ustaalioglu BB; Kefeli U; Yildirim E; Yavuzer D; Aydin FM; Salepci T; Oncel M; Gumus M
    Ann Surg Oncol; 2010 Aug; 17(8):2037-44. PubMed ID: 20333555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic indicators in node-negative advanced gastric cancer patients.
    Saito H; Kuroda H; Matsunaga T; Fukuda K; Tatebe S; Tsujitani S; Ikeguchi M
    J Surg Oncol; 2010 Jun; 101(7):622-5. PubMed ID: 20461771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic study of advanced gastric cancer without serosal invasion in young and old patients.
    Wang JY; Hsieh JS; Huang CJ; Huang YS; Huang TJ
    J Surg Oncol; 1996 Sep; 63(1):36-40. PubMed ID: 8841464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multivariate prognostic study on large gastric cancer.
    Shiraishi N; Sato K; Yasuda K; Inomata M; Kitano S
    J Surg Oncol; 2007 Jul; 96(1):14-8. PubMed ID: 17582596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive factors for lymph node metastasis in early gastric cancer with submucosal invasion: analysis of a single institutional experience.
    An JY; Baik YH; Choi MG; Noh JH; Sohn TS; Kim S
    Ann Surg; 2007 Nov; 246(5):749-53. PubMed ID: 17968165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of splenic hilar lymph node metastasis in proximal gastric cancer.
    Shin SH; Jung H; Choi SH; An JY; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S
    Ann Surg Oncol; 2009 May; 16(5):1304-9. PubMed ID: 19241107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed-histologic-type submucosal invasive gastric cancer as a risk factor for lymph node metastasis: feasibility of endoscopic submucosal dissection.
    Hanaoka N; Tanabe S; Mikami T; Okayasu I; Saigenji K
    Endoscopy; 2009 May; 41(5):427-32. PubMed ID: 19418397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.